Post-Transplant Maintenance Therapy With Isatuximab Plus Lenalidomide for High-Risk Multiple Myeloma Patients

NCT05776979 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Isatuximab
DRUG: lenalidomide

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]